Stocks
Guardant Health (GH) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -25.6% | -78.5% | -96.2% | -136.8% | -76.8% | -70.5% | ||
| Changes by years, y/y, % | +66pp | -53pp | -18pp | -41pp | +60pp | -3.4% | |||
Guardant Health. EBITDA margin, %
Guardant Health. EBITDA margin, changes, pp
Guardant Health (GH) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -51.7% | -113.6% | -61.3% | -51.4% | -61.3% | -70.5% | |
| Changes by years, y/y, % | +77pp | -4pp | +42pp | +1pp | -10pp | |||
| Changes by quarters, q/q, % | +1pp | -62pp | +52pp | +10pp | -10pp | |||
